News
Orchid Pharma reports consolidated net profit of Rs 3.22 crore in the June 2026 quarter
15-Aug-2026 | 14:44
Sales rise 15.57% to Rs 304.17 crore
Net profit of Orchid Pharma reported to Rs 3.22 crore in the quarter ended June 2026 as against net loss of Rs 5.69 crore during the previous quarter ended June 2025. Sales rose 15.57% to Rs 304.17 crore in the quarter ended June 2026 as against Rs 263.19 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 304.17 | 263.19 | 16 |
| OPM % | 4.60 | -2.14 | - |
| PBDT | 13.60 | 3.64 | 274 |
| PBT | 2.65 | -6.89 | LP |
| NP | 3.22 | -5.69 | LP |
Powered by Capital Market - Live News